Ten novel usnic acid based imidazolium salts were synthesized by employing a two-step protocol. The anti-inflammatory potential of the newly synthesised compounds was evaluated in vitro against cytokine proteins TNF- α and IL-1 β secreted from U937 cells. Some of the imidazolium salts exhibited promising anti-inflammatory activity against the TNF-α and IL-1β with IC50 values ranging between 5.3 μM - 7.5 μM, which are many folds lower than that of the parent compound (>100 μM). Most significantly, substitution with electronegative groups in imidazolium salts of usnic acid found to be more potent and exhibiting enhanced anti-inflammatory activity.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Download PDF 
Post
